1. Home
  2. VECO vs AUPH Comparison

VECO vs AUPH Comparison

Compare VECO & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VECO
  • AUPH
  • Stock Information
  • Founded
  • VECO 1945
  • AUPH 1993
  • Country
  • VECO United States
  • AUPH Canada
  • Employees
  • VECO N/A
  • AUPH N/A
  • Industry
  • VECO Industrial Machinery/Components
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • VECO Technology
  • AUPH Health Care
  • Exchange
  • VECO Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • VECO 1.0B
  • AUPH 999.8M
  • IPO Year
  • VECO 1994
  • AUPH 1999
  • Fundamental
  • Price
  • VECO $19.21
  • AUPH $8.00
  • Analyst Decision
  • VECO Buy
  • AUPH Strong Buy
  • Analyst Count
  • VECO 7
  • AUPH 2
  • Target Price
  • VECO $30.43
  • AUPH $11.50
  • AVG Volume (30 Days)
  • VECO 736.6K
  • AUPH 971.5K
  • Earning Date
  • VECO 05-07-2025
  • AUPH 05-12-2025
  • Dividend Yield
  • VECO N/A
  • AUPH N/A
  • EPS Growth
  • VECO N/A
  • AUPH N/A
  • EPS
  • VECO 1.07
  • AUPH 0.04
  • Revenue
  • VECO $710,109,000.00
  • AUPH $235,133,000.00
  • Revenue This Year
  • VECO N/A
  • AUPH $11.86
  • Revenue Next Year
  • VECO $8.64
  • AUPH $24.96
  • P/E Ratio
  • VECO $18.02
  • AUPH $199.38
  • Revenue Growth
  • VECO 3.30
  • AUPH 33.97
  • 52 Week Low
  • VECO $16.92
  • AUPH $4.98
  • 52 Week High
  • VECO $49.25
  • AUPH $10.67
  • Technical
  • Relative Strength Index (RSI)
  • VECO 48.92
  • AUPH 48.76
  • Support Level
  • VECO $18.31
  • AUPH $7.89
  • Resistance Level
  • VECO $20.46
  • AUPH $8.38
  • Average True Range (ATR)
  • VECO 0.78
  • AUPH 0.24
  • MACD
  • VECO 0.19
  • AUPH 0.01
  • Stochastic Oscillator
  • VECO 56.90
  • AUPH 39.68

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for our customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: